120 related articles for article (PubMed ID: 11525909)
21. Sister chromatid exchanges and DNA topoisomerase II inhibitors: effect of low concentrations of etoposide (VP-16) in ataxia telangiectasia lymphoblastoid cell lines.
Fantini C; Vernole P; Tedeschi B; Caporossi D
Mutat Res; 1998 Jan; 412(1):1-7. PubMed ID: 9508359
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of DNA topoisomerase II by ICRF-193 induces polyploidization by uncoupling chromosome dynamics from other cell cycle events.
Ishida R; Sato M; Narita T; Utsumi KR; Nishimoto T; Morita T; Nagata H; Andoh T
J Cell Biol; 1994 Sep; 126(6):1341-51. PubMed ID: 8089169
[TBL] [Abstract][Full Text] [Related]
23. DNA repair deficiency and BPDE-induced chromosomal alterations in CHO cells.
Meschini R; Marotta E; Berni A; Filippi S; Fiore M; Mancinelli P; Natarajan AT; Palitti F
Mutat Res; 2008 Jan; 637(1-2):93-100. PubMed ID: 17720205
[TBL] [Abstract][Full Text] [Related]
24. Cytogenetic evaluation of the mechanism of cell death induced by the novel anthracenyl-amino acid topoisomerase II catalytic inhibitor NU/ICRF 500.
Cummings J; Sumner AT; Slavotinek A; Meikle I; Macpherson JS; Smyth JF
Mutat Res; 1995 Aug; 344(1-2):55-62. PubMed ID: 7565893
[TBL] [Abstract][Full Text] [Related]
25. Chromosomal instability in mutagen-sensitive mutants isolated from mouse lymphoma L5178Y cells. II. Abnormal induction of sister-chromatid exchanges and chromosomal aberrations by mutagens in an ionizing radiation-sensitive mutant (M10) and an alkylating agent-sensitive mutant (MS1).
Tsuji H; Takahashi E; Tsuji S; Tobari I; Shiomi T; Sato K
Mutat Res; 1987 May; 178(1):107-16. PubMed ID: 3106796
[TBL] [Abstract][Full Text] [Related]
26. ICRF-193, a catalytic inhibitor of DNA topoisomerase II, delays the cell cycle progression from metaphase, but not from anaphase to the G1 phase in mammalian cells.
Iwai M; Hara A; Andoh T; Ishida R
FEBS Lett; 1997 Apr; 406(3):267-70. PubMed ID: 9136899
[TBL] [Abstract][Full Text] [Related]
27. Analyzing Mitotic Chromosome Structural Defects After Topoisomerase II Inhibition or Mutation.
Giménez-Abián JF; Lane AB; Clarke DJ
Methods Mol Biol; 2018; 1703():191-215. PubMed ID: 29177744
[TBL] [Abstract][Full Text] [Related]
28. Importance of replication fork progression for the induction of chromosome damage and SCE by inhibitors of DNA topoisomerases.
Cortés F; Piñero J; Ortiz T
Mutat Res; 1993 Oct; 303(2):71-6. PubMed ID: 7692280
[TBL] [Abstract][Full Text] [Related]
29. Genetic profile of a nalidixic acid analog: a model for the mechanism of sister chromatid exchange induction.
Holden HE; Barett JF; Huntington CM; Muehlbauer PA; Wahrenburg MG
Environ Mol Mutagen; 1989; 13(3):238-52. PubMed ID: 2539998
[TBL] [Abstract][Full Text] [Related]
30. Bufalin reduces the level of topoisomerase II in human leukemia cells and affects the cytotoxicity of anticancer drugs.
Hashimoto S; Jing Y; Kawazoe N; Masuda Y; Nakajo S; Yoshida T; Kuroiwa Y; Nakaya K
Leuk Res; 1997 Sep; 21(9):875-83. PubMed ID: 9393603
[TBL] [Abstract][Full Text] [Related]
31. Higher G2 sensitivity to the induction of chromosomal damage in the CHO mutant EM9 than in its parental line AA8 by camptothecin, an inhibitor of DNA topoisomerase I.
Palitti F; Cortés F; Bassi L; Di Chiara D; Fiore M; Pinero J
Mutat Res; 1993 Feb; 285(2):281-5. PubMed ID: 7678901
[TBL] [Abstract][Full Text] [Related]
32. DNA repair deficiency and acetaldehyde-induced chromosomal alterations in CHO cells.
Mechilli M; Schinoppi A; Kobos K; Natarajan AT; Palitti F
Mutagenesis; 2008 Jan; 23(1):51-6. PubMed ID: 17989147
[TBL] [Abstract][Full Text] [Related]
33. The production of chromosomal alterations in human lymphocytes by drugs known to interfere with the activity of DNA topoisomerase II. I. m-AMSA.
Andersson HC; Kihlman BA
Carcinogenesis; 1989 Jan; 10(1):123-30. PubMed ID: 2535969
[TBL] [Abstract][Full Text] [Related]
34. Effects of DNA topoisomerase inhibitors on nonhomologous and homologous recombination in mammalian cells.
Aratani Y; Andoh T; Koyama H
Mutat Res; 1996 Feb; 362(2):181-91. PubMed ID: 8596537
[TBL] [Abstract][Full Text] [Related]
35. Okadaic acid, a protein phosphatase inhibitor, induces sister-chromatid exchanges depending on the presence of bromodeoxyuridine.
Tohda H; Nagao M; Sugimura T; Oikawa A
Mutat Res; 1993 Oct; 289(2):275-80. PubMed ID: 7690896
[TBL] [Abstract][Full Text] [Related]
36. Effect of novobiocin on the frequencies of chromatid-type aberrations and sister-chromatid exchanges following gamma-irradiation.
Takahashi K; Kaneko I; Nishiyama C; Nakano K
Mutat Res; 1985 Dec; 144(4):265-70. PubMed ID: 2999586
[TBL] [Abstract][Full Text] [Related]
37. Cytogenetic evidence that DNA topoisomerase II is not involved in radiation induced chromsome-type aberrations.
Mosesso P; Pepe G; Ottavianelli A; Schinoppi A; Cinelli S
Mutat Res Genet Toxicol Environ Mutagen; 2015 Nov; 793():14-8. PubMed ID: 26520368
[TBL] [Abstract][Full Text] [Related]
38. Sister-chromatid exchanges (SCE) induction by inhibitors of DNA topoisomerases in cultured human lymphocytes.
Ribas G; Xamena N; Creus A; Marcos R
Mutat Res; 1996 Jul; 368(3-4):205-11. PubMed ID: 8692226
[TBL] [Abstract][Full Text] [Related]
39. Influence of inhibitors of poly(ADP-ribose) polymerase on DNA repair, chromosomal alterations, and mutations.
Natarajan AT; van Zeeland AA; Zwanenburg TS
Princess Takamatsu Symp; 1983; 13():227-42. PubMed ID: 6317638
[TBL] [Abstract][Full Text] [Related]
40. ICRF-193, a catalytic inhibitor of DNA topoisomerase II, inhibits re-entry into the cell division cycle from quiescent state in mammalian cells.
Hossain MS; Akimitsu N; Takaki T; Hirai H; Sekimizu K
Genes Cells; 2002 Mar; 7(3):285-94. PubMed ID: 11918672
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
